April 14, 2021
The webinar will review the current data supporting the approvals for immune checkpoint inhibitors. Cases will be utilized to highlight the direct clinical application.
At the conclusion of the activity, participants will be able to:
Define the current approved indications for immune checkpoint inhibitors.
Kevin Emerick, MD, Massachusetts Eye & Ear Infirmary
Gina Jefferson, MD, MS, The University of Mississippi Medical Center
Miriam Lango, MD, MD Anderson Cancer Center
David Miller, MD, PhD, Massachusetts General Cancer Center
Matthew Witek, MD, MS, University of Maryland School of Medicine